Clinical Trial Update: A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating perioperative epoetin alfa (PROCRIT) for safety and efficacy in blood conservation during major elective spinal surgery, compared with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Venous Thrombosis

Drugs mentioned

• PROCRIT (ERYTHROPOIETIN)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia, Venous Thrombosis | Phase 3 | Status: COMPLETED